Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

Idenix Pharmaceuticals, Inc. · Cambridge, MA United States ·(NASDAQ (GM): IDIX)

Company Description

60 Hampshire St.
Cambridge, MA
02139
United States (Map)
Phone: 617-995-9800
Fax: 617-995-9801
    View Idenix Pharmaceuticals, Inc. Locations On A US MapThis link will open in a new window
    Idenix Pharmaceuticals is not suffering from any identity crisis -- it is clear in its focus on identifying treatments for life-threatening viruses. The biopharmaceutical firm is developing orally administered drugs to combat chronic hepatitis C (HCV) and HIV. Its lead HIV product candidate is in early clinical stages; its HCV candidates are in preclinical testing. Most are intended to be taken in combination with other therapeutic agents to improve efficacy and convenience. Under a development and commercialization agreement, Novartis has the option to license any of the product candidates developed by Idenix. Novartis owns 56% of Idenix. To read the full description, subscribe now.
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    Key Idenix Pharmaceuticals, Inc. Financials

    Company TypePublic - NASDAQ (GM): IDIX

    Headquarters
    Fiscal Year-EndDecember
    2008 Sales (mil.)$10.0
    2008 Employees173

    Idenix Pharmaceuticals, Inc. Executives

    20 executives listed for Idenix Pharmaceuticals, Inc.'s Cambridge, MA location.
    TitleName & BioContact
    Chairman, President, and CEOJean-Pierre SommadossiNetwork
    CFO and TreasurerRonald RenaudNetwork
    EVP and Chief Medical OfficerDouglas MayersNetwork

    Competition

    Top Idenix Pharmaceuticals, Inc. Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!